Skip to main content

Articles

Page 12 of 26

  1. The article discusses and analyzes the changes that have taken place since 2016 in Israeli policy with regard to the treatment, diagnosis and detection of hepatitis C (HCV) in prison settings. The article find...

    Authors: Niv Michaeli, Anat Litvin and Nadav Davidovitch
    Citation: Harm Reduction Journal 2020 17:79
  2. There are an estimated 3.2 million women who inject drugs worldwide, constituting 20% of all people who inject drugs. The limited data that are available suggest that women who inject drugs are at greater risk...

    Authors: Sam Shirley-Beavan, Aura Roig, Naomi Burke-Shyne, Colleen Daniels and Robert Csak
    Citation: Harm Reduction Journal 2020 17:78
  3. We characterized the extent and quality of respiratory sensations and sensory-related smoking cues associated with e-cigarette use among those who failed to quit combustible tobacco cigarette (CTC) use with tr...

    Authors: J. DiPiazza, P. Caponnetto, G. Askin, P. Christos, M. Lyc Psych Maglia, R. Gautam, S. Roche and R. Polosa
    Citation: Harm Reduction Journal 2020 17:75
  4. In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-us...

    Authors: Michael Liebrenz, Alex Gamma, Anna Buadze, Roman Schleifer, Stéphanie Baggio, Bruce Schwartz, Andres Schneeberger and Ambros Uchtenhagen
    Citation: Harm Reduction Journal 2020 17:67
  5. West Virginia is a largely rural state with strong ties of kinship, mutual systems of support and charitable giving. At the same time, wealth inequalities are extreme and the state’s drug overdose fatality rat...

    Authors: Jeff Ondocsin, Sarah G. Mars, Mary Howe and Daniel Ciccarone
    Citation: Harm Reduction Journal 2020 17:74

    The Correction to this article has been published in Harm Reduction Journal 2021 18:94

  6. Smoking is endemic amongst people accessing homeless services, and they are disproportionately affected by smoking-related diseases. This paper reports on the results of a 3-month small scale intervention whic...

    Authors: Florian Scheibein, Kevin McGirr, Andy Morrison, Warren Roche and John Stephen Gary Wells
    Citation: Harm Reduction Journal 2020 17:73

    The Correction to this article has been published in Harm Reduction Journal 2021 18:113

  7. Most of the existing research on supervised consumption services (SCS) is focused on injection drug use. Less is known about the applicability of SCS for people who consume drugs orally, intranasally, or throu...

    Authors: Kelsey A. Speed, Nicole D. Gehring, Katherine Launier, Daniel O’Brien, Sandy Campbell and Elaine Hyshka
    Citation: Harm Reduction Journal 2020 17:72
  8. E-cigarettes are the most popular aid to smoking cessation attempts in England and the USA. This research examined associations between e-cigarette device characteristics and patterns of use, tobacco-smoking r...

    Authors: Sarah Victoria Gentry, Emma Ward, Lynne Dawkins, Richard Holland and Caitlin Notley
    Citation: Harm Reduction Journal 2020 17:70
  9. Opioid agonist treatment (OAT) is an effective method of addiction treatment and HIV prevention. However, globally, people who inject drugs (PWID) have insufficient OAT uptake. To expand OAT access and uptake,...

    Authors: Tetiana Kiriazova, Vivian F. Go, Rebecca B. Hershow, Erica L. Hamilton, Riza Sarasvita, Quynh Bui, Kathryn E. Lancaster, Kostyantyn Dumchev, Irving F. Hoffman, William C. Miller and Carl A. Latkin
    Citation: Harm Reduction Journal 2020 17:69
  10. Opioid substitution therapy (OST) with buprenorphine has been widely available in India since 2007, but the introduction of methadone occurred much later in 2012, and availability remains limited. Illicit inje...

    Authors: Michelle Kermode, Robedi Sharma Choudhurimayum, Lenin Singh Rajkumar, Tilahun Haregu and Greg Armstrong
    Citation: Harm Reduction Journal 2020 17:68
  11. Understanding the association between methamphetamine (MA) use and HIV risk behavior among people who inject drugs (PWID) will assist policy-makers and program managers to sharpen the focus of HIV prevention i...

    Authors: Mehdi Noroozi, Peter Higgs, Alireza Noroozi, Bahram Armoon, Bentolhoda Mousavi, Rosa Alikhani, Mohammad Rafi Bazrafshan, Ali Nazeri Astaneh, Azadeh Bayani and Ladan Fattah Moghaddam
    Citation: Harm Reduction Journal 2020 17:66
  12. Electronic cigarettes (e-cigarettes) have been characterised as significantly less harmful than cigarettes by many health agencies and regulators globally. In this study, we examined to what extent perceived r...

    Authors: Layla Malt, Thomas Verron, Xavier Cahours, Mengran Guo, Sarah Weaver, Tanvir Walele and Grant O’Connell
    Citation: Harm Reduction Journal 2020 17:65
  13. Most people diagnosed with hepatitis C virus (HCV) have not linked to care, despite the availability of safe and effective treatment. We aimed to understand why people diagnosed with HCV have not pursued care ...

    Authors: Jacqueline E. Sherbuk, Alexa Tabackman, Kathleen A. McManus, Terry Kemp Knick, Julie Schexnayder, Tabor E. Flickinger and Rebecca Dillingham
    Citation: Harm Reduction Journal 2020 17:64
  14. Tampering of psychoactive medicines presents challenges to regulation and public health. However, little is currently known about what influences the decisions to treat codeine-containing medicines (CCM) with ...

    Authors: Andreas Kimergård, Stephen Parkin, Stacey Jennings, Eileen Brobbin and Paolo Deluca
    Citation: Harm Reduction Journal 2020 17:63
  15. Injecting drug use is known to contribute significantly to the spread of the HIV epidemic in many parts of the developing world. Due to the hidden nature and stigma of the problem, it is difficult to study usi...

    Authors: Negussie Deyessa, Bekele Senbete, Aman Abdo and Bernard M. Mundia
    Citation: Harm Reduction Journal 2020 17:61
  16. Caledonian Stadium, the main mass temporary shelter for homeless people in the City of Tshwane, was created as a local response to the imperatives of the novel coronavirus disease (COVID-19) National State of ...

    Authors: Tessa S. Marcus, Jan Heese, Andrew Scheibe, Shaun Shelly, Sasha X. Lalla and Jannie F. Hugo
    Citation: Harm Reduction Journal 2020 17:60
  17. Despite multiple harm reduction (HR) programmes worldwide, there are still an important number of people who use drugs (PWUD) who do not access those services. Their difficulties to obtain HR tools are due to ...

    Authors: Magally Torres-Leguizamon, Emmanuel G. Reynaud, Thomas Néfau and Catherine Duplessy
    Citation: Harm Reduction Journal 2020 17:59
  18. People who smoke drugs (PWSD) are at high risk of both infectious disease and overdose. Harm reduction activities organized by their peers in the community can reduce risk by providing education, safer smoking...

    Authors: Sulaf Elkhalifa, Ehsan Jozaghi, Samona Marsh, Erica Thomson, Delilah Gregg, Jane Buxton and Ann Jolly
    Citation: Harm Reduction Journal 2020 17:57
  19. Hepatitis C virus (HCV) is among the highest priority diseases in custodial settings; however, the diagnosis remains suboptimal among people in custody. This study aimed to validate a short survey for identify...

    Authors: Sanam Hariri, Maryam Sharafkhah, Maryam Alavi, Gholamreza Roshandel, Abdolreza Fazel, Taghi Amiriani, Nazgol Motamed-Gorji, Abolfazl Bazazan, Shahin Merat, Hossein Poustchi and Reza Malekzadeh
    Citation: Harm Reduction Journal 2020 17:56
  20. After the collapse of the Soviet Union at the beginning of the 1990s, people who inject drugs spiked in Eastern Europe. Facing local repression and an array of factors encouraging emigration, some users have m...

    Authors: Yaël Tibi-Lévy, Daria Serebryakova and Marie Jauffret-Roustide
    Citation: Harm Reduction Journal 2020 17:55
  21. People who inject drugs (PWID) are a medically and socially vulnerable population with a high incidence of overdose, mental illness, and infections like HIV and hepatitis C. Existing literature describes socia...

    Authors: Brandon Muncan, Suzan M. Walters, Jerel Ezell and Danielle C. Ompad
    Citation: Harm Reduction Journal 2020 17:53
  22. Few data on motivations for using new psychoactive substances (NPS) are available. However, the cost, the legal status, and their accessibility through channels like internet contributed to the popularity of N...

    Authors: Sarah Simonis, Michaël Canfyn, Anton Van Dijck, Tina Van Havere, Eric Deconinck, Peter Blanckaert and Lies Gremeaux
    Citation: Harm Reduction Journal 2020 17:52
  23. Due to the high prevalence of mental disorders among people with opioid use disorder, the objective of this study was to determine the association between concurrent mental disorders, mortality, morbidity, and...

    Authors: Kristen A. Morin, Joseph K. Eibl, Graham Gauthier, Brian Rush, Christopher Mushquash, Nancy E. Lightfoot and David C. Marsh
    Citation: Harm Reduction Journal 2020 17:51
  24. Opioid agonist therapy (OAT) uptake has been associated with multiple positive health outcomes among people who inject drugs (PWID). This study evaluated the pattern of OAT uptake among PWID in two consecutive...

    Authors: Mehran Nakhaeizadeh, Zahra Abdolahinia, Hamid Sharifi, Ali Mirzazadeh, Ali Akbar Haghdoost, Mostafa Shokoohi, Stefan Baral, Mohammad Karamouzian and Armita Shahesmaeili
    Citation: Harm Reduction Journal 2020 17:50
  25. Needle syringe programs (NSPs), a proven harm reduction strategy for people who inject drugs, frequently offer limited healthcare services for their clients. Women who inject drugs face multiple barriers to ac...

    Authors: Lauren Owens, Kelly Gilmore, Mishka Terplan, Sarah Prager and Elizabeth Micks
    Citation: Harm Reduction Journal 2020 17:47
  26. Switching from smoking to using nicotine replacement therapy (NRT), electronic cigarettes (e-cigarettes) or heated tobacco products can reduce tobacco-related health risks. However, not all smokers in Great Br...

    Authors: Erikas Simonavicius, Ann McNeill, Hazel Cheeseman, Deborah Arnott and Leonie S. Brose
    Citation: Harm Reduction Journal 2020 17:46
  27. Population models have been developed to evaluate the impact of new tobacco products on the overall population. Reliable input parameters such as longitudinal tobacco use transitions are needed to quantify the...

    Authors: Lai Wei, Raheema S. Muhammad-Kah, Thaddaeus Hannel, Yezdi B. Pithawalla, Maria Gogova, Simeon Chow and Ryan A. Black
    Citation: Harm Reduction Journal 2020 17:45
  28. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Marcus Castillo, Margaret E. C. Ginoza, Tyler S. Bartholomew, David W. Forrest, Costaki Greven, David P. Serota and Hansel E. Tookes
    Citation: Harm Reduction Journal 2020 17:44

    The original article was published in Harm Reduction Journal 2020 17:34

  29. Research suggests sexual minority female sex workers (SM-FSW) face elevated structural vulnerability and HIV risk compared to their heterosexual counterparts. Structural vulnerabilities reflect societal level ...

    Authors: Jennifer L. Glick, Sahnah Lim, S. Wilson Beckham, Catherine Tomko, Ju Nyeong Park and Susan G. Sherman
    Citation: Harm Reduction Journal 2020 17:43
  30. A primary consequence of illicit drug markets and the absence of regulation is the variable quality or purity of the final product. Analysis of anabolic-androgenic steroid seizures shows that these products ca...

    Authors: Evelyn Frude, Fiona H. McKay and Matthew Dunn
    Citation: Harm Reduction Journal 2020 17:42
  31. Methamphetamine use poses a barrier to antiretroviral therapy (ART) adherence. Black and Hispanic men who have sex with men living with HIV (PLWH) shoulder much of the health burden resulting from the methamph...

    Authors: Elizabeth C. Pasipanodya, Maulika Kohli, Celia B. Fisher, David J. Moore and Brenda Curtis
    Citation: Harm Reduction Journal 2020 17:41
  32. Blood-borne viral infections, such as HIV and hepatitis C (HCV), are common infections among people who inject drugs (PWID). This study aims to determine the prevalence of HIV and HCV infection among PWID acce...

    Authors: Tyler S. Bartholomew, Jason Onugha, Corinne Bullock, Carolina Scaramutti, Hardik Patel, David W. Forrest, Daniel J. Feaster and Hansel E. Tookes
    Citation: Harm Reduction Journal 2020 17:40
  33. Treatment of hepatitis C (HCV) among people who inject drugs (PWID) is a critical component of efforts to eliminate viral hepatitis. A recent study found high HCV prevalence among PWID in two cities, Pretoria ...

    Authors: Anna Versfeld, Angela McBride, Andrew Scheibe and C. Wendy Spearman
    Citation: Harm Reduction Journal 2020 17:39
  34. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Magdalena Harris, Jenny Scott, Vivian Hope, Talen Wright, Catherine McGowan and Daniel Ciccarone
    Citation: Harm Reduction Journal 2020 17:38

    The original article was published in Harm Reduction Journal 2020 17:24

  35. In 2016, the Australian federal government passed legislation enabling a range of cannabis-based products to be prescribed to patients by registered healthcare professionals. An online survey conducted immedia...

    Authors: Nicholas Lintzeris, Llewellyn Mills, Anastasia Suraev, Maria Bravo, Thomas Arkell, Jonathon C. Arnold, Melissa J. Benson and Iain S. McGregor
    Citation: Harm Reduction Journal 2020 17:37
  36. Using snus (Swedish moist snuff) is less harmful than smoking, but health warning labels (HWLs) on snus products do not reflect this relation. There are few studies on the effects of comparative risk informati...

    Authors: Connie Villemo Nilsen, Torleif Halkjelsvik and Frode Svartdal
    Citation: Harm Reduction Journal 2020 17:36
  37. The rising incidence of infective endocarditis (IE) among people who inject drugs (PWID) has been a major concern across North America. The coincident rise in IE and change of drug preference to hydromorphone ...

    Authors: Meera Shah, Ryan Wong, Laura Ball, Klajdi Puka, Charlie Tan, Esfandiar Shojaei, Sharon Koivu and Michael Silverman
    Citation: Harm Reduction Journal 2020 17:35
  38. Syringe services programs (SSPs) are able to offer wrap-around services for people who inject drugs (PWID) and improve health outcomes.

    Authors: Marcus Castillo, Margaret E. C. Ginoza, Tyler S. Bartholomew, David W. Forrest, Costaki Greven, David P. Serota and Hansel E. Tookes
    Citation: Harm Reduction Journal 2020 17:34

    The Correction to this article has been published in Harm Reduction Journal 2020 17:44

  39. For novel tobacco products that potentially reduce the risk of tobacco harm, post-market surveillance is important to observe population usage and behaviours associated with everyday use. This pilot study was ...

    Authors: Jason Adamson, Claudia Kanitscheider, Krishna Prasad, Oscar M. Camacho, Elisabeth Beyerlein, Yoga Keralapura Bhagavan, Christopher Proctor and James Murphy
    Citation: Harm Reduction Journal 2020 17:32
  40. With a worldwide prevalence of 15.4%, hepatitis C virus (HCV) has been estimated to be the most prevalent major infectious disease in prisons. The exceptionally high prevalence of HCV in prisons is attributabl...

    Authors: Babak Moazen, Heino Stöver, Kate Dolan, Albrecht Jahn and Florian Neuhann
    Citation: Harm Reduction Journal 2020 17:33
  41. Naloxone is a safe and effective medication to help reverse opioid overdose. Providing take-home naloxone to patients in opioid treatment settings is a critical step to reducing opioid overdose deaths. In New ...

    Authors: Julie G. Salvador, Andrew L. Sussman, Mikiko Y. Takeda, William G. Katzman, Monica Moya Balasch and Joanna G. Katzman
    Citation: Harm Reduction Journal 2020 17:31
  42. Syringe services programs (SSPs) are an evidence-based harm reduction strategy that reduces dangerous sequelae of injection drug use among people who inject drugs (PWID) such as overdose. SSP services include ...

    Authors: K. J. Bornstein, A. E. Coye, J. E. St. Onge, H. Li, A. Muller, T. S. Bartholomew and H. E. Tookes
    Citation: Harm Reduction Journal 2020 17:30